Serum vaccine antibody concentrations in adults exposed to per- and polyfluoroalkyl substances: A birth cohort in the Faroe Islands

References

• Ait Bamai Y, Goudarzi H, Araki A, Okada E, Kashino I, Miyashita C, Kishi R. 2020. Effect of prenatal exposure to per- and polyfluoroalkyl substances on childhood allergies and common infectious diseases in children up to age 7 years: the Hokkaido study on environment and children's health. Environ Intl. 143:105979.
   PubMed Web of Science ®Google Scholar
• Austin P. 2011. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharmaceut Statist. 10(2):150–161.
   PubMed Web of Science ®Google Scholar
• Authority EEFS. 2005. Opinion of the scientific panel on contaminants in the food chain on a request from the commission related to a presence of non differences polychlorinated biphenyls (PCB) in feed and food. EFSA J. 2005(284):1–137.
   Google Scholar
• Averina M, Brox J, Huber S, Furberg A, Sørensen M. 2019. Serum perfluoroalkyl substances (PFAS) and risk of asthma and various allergies in adolescents. The Tromsø study Fit Futures in Northern Norway. Environ Res. 169:114–121.
   PubMed Web of Science ®Google Scholar
• Bassler J, Ducatman A, Elliott M, Wen S, Wahlang B, Barnett J, Cave M. 2019. Environmental perfluoroalkyl acid exposures are associated with liver disease characterized by apoptosis and altered serum adipocytokines. Environ Pollut. 247:1055–1063.
   PubMed Web of Science ®Google Scholar
• Berbudi A, Rahmadika N, Tjahjadi A, Ruslami R. 2020. Type 2 diabetes and its impact on the immune system. Curr Diabetes Rev. 16(5):442–449.
   PubMed Web of Science ®Google Scholar
• Cardenas A, Hauser R, Gold D, Kleinman K, Hivert M, Fleisch A, Lin P, Calafat A, Webster T, Horton E, et al. 2018. Association of perfluoroalkyl and polyfluoroalkyl substances with adiposity. JAMA Netw Open. 1(4):e181493.
   PubMed Web of Science ®Google Scholar
• Chen Q, Huang R, Hua L, Guo Y, Huang L, Zhao Y, Wang X, Zhang J. 2018. Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and childhood atopic dermatitis: A prospective birth cohort study. Environ Health. 17(8).
   Google Scholar
• Corsini E, Luebke R, Germolec D, DeWitt J. 2014. Perfluorinated compounds: Emerging POPs with potential immunotoxicity. Toxicol Lett. 230(2):263–270.
   PubMed Web of Science ®Google Scholar
• Dalsager L, Christensen N, Halekoh U, Timmermann C, Nielsen F, Kyhl H, Husby S, Grandjean P, Jensen T, Andersen H. 2021. Exposure to perfluoroalkyl substances during fetal life and hospitalization for infectious disease in childhood: A study among 1,503 children from the Odense Child Cohort. Environ Intl. 149(106395):106395.
   PubMedGoogle Scholar
• Dalsager L, Christensen N, Husby S, Kyhl H, Nielsen F, Høst A, Grandjean P, Jensen T. 2016. Association between prenatal exposure to perfluorinated compounds and symptoms of infections at age 1-4years among 359 children in the Odense Child Cohort. Environ Intl. 96:58–64.
   PubMed Web of Science ®Google Scholar
• DeWitt J, Blossom S, Schaider L. 2019. Exposure to per-fluoroalkyl and polyfluoroalkyl substances leads to immunotoxicity: Epidemiological and toxicological evidence. J Expo Sci Environ Epidemiol. 29(2):148–156.
   PubMed Web of Science ®Google Scholar
• DeWitt J, Williams W, Creech N, Luebke R. 2016. Suppression of antigen-specific antibody responses in mice exposed to perfluorooctanoic acid: role of PPARa and T- and B-cell targeting. J. Immunotoxicol. 13(1):38–45.
   PubMed Web of Science ®Google Scholar
• Dobner J, Kaser S. 2018. Body mass index and the risk of infection – from underweight to obesity. Clin Microbiol Infect. 24(1):24–28.
   PubMed Web of Science ®Google Scholar
• Edwards M, Dai R, Ahmed S. 2018. Our environment shapes us: The importance of environment and sex differences in regulation of autoantibody production. Front Immunol. 9:478.
   PubMed Web of Science ®Google Scholar
• Goudarzi H, Miyashita C, Okada E, Kashino I, Chen CJ, Ito S, Araki A, Kobayashi S, Matsuura H, Kishi R. 2017. Prenatal exposure to perfluoroalkyl acids and prevalence of infectious diseases up to 4 years of age. Environ Intl. 104:132–138.
   PubMed Web of Science ®Google Scholar
• Grandjean P, Andersen E, Budtz-Jørgensen E, Nielsen F, Mølbak K, Weihe P, Heilmann C. 2012. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA. 307(4):391–397.
   PubMed Web of Science ®Google Scholar
• Grandjean P, Heilmann C, Weihe P, Nielsen F, Mogensen UB, Budtz-Jorgensen E. 2017a. Serum vaccine antibody concentrations in adolescents exposed to perfluorinated compounds. Environ Health Perspect. 125(7):077018.
   PubMed Web of Science ®Google Scholar
• Grandjean P, Heilmann C, Weihe P, Nielsen F, Mogensen UB, Timmermann A, Budtz-Jorgensen E. 2017b. Estimated exposures to perfluorinated compounds in infancy predict attenuated vaccine antibody concentrations at age 5-years. J Immunotoxicol. 14(1):188–195.
   PubMed Web of Science ®Google Scholar
• Grandjean P, Weihe P, Jorgensen P, Clarkson T, Cernichiari E, Videro T. 1992. Impact of maternal seafood diet on fetal exposure to mercury, selenium, and lead. Arch Environ Health. 47(3):185–195.
   PubMed Web of Science ®Google Scholar
• Grandjean P, Weihe P, White R, Debes F, Araki S, Yokoyama K, Murata K, Sorensen N, Dahl R, Jorgensen P. 1997. Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol. 19(6):417–428.
   PubMed Web of Science ®Google Scholar
• Granum B, Haug LS, Namork E, Stølevik SB, Thomsen C, Aaberge I, van Loveren H, Løvik M, Nygaard U. 2013. Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood. J Immunotoxicol. 10(4):373–379.
   PubMed Web of Science ®Google Scholar
• Harada K, Saito N, Inoue K, Yoshinaga T, Watanabe T, Sasaki S, Kamiyama S, Koizumi A. 2004. The influence of time, sex and geographic factors on levels of perfluorooctane sulfonate and perfluoro-octanoate in human serum over the last 25 years. Jrnl of Occup Health. 46(2):141–147.
   PubMed Web of Science ®Google Scholar
• Haug L, Thomsen C, Becher G. 2009. A sensitive method for determination of a broad range of perfluorinated compounds in serum suitable for large-scale human biomonitoring. J Chromatogr A. 1216(3):385–393.
   PubMed Web of Science ®Google Scholar
• Hendriksen CF, Vd Gun JW, Nagel J, Kreeftenberg JG. 1988. The toxin binding inhibition test as a reliable in vitro alternative to the toxin neutralization test in mice for the estimation of tetanus antitoxin in human sera. J Biol Stand. 16(4):287–297.
   PubMedGoogle Scholar
• Huang H, Yu K, Zeng X, Chen Q, Liu Q, Zhao Y, Zhang J, Zhang X, Huang L. 2020. Association between prenatal exposure to perfluoroalkyl substances and respiratory tract infections in preschool children. Environ Res. 191:110156.
   PubMed Web of Science ®Google Scholar
• Ilavská S, Horváthová M, Szabová M, Nemessányi T, Jahnová E, Tulinská J, Líšková A, Wsolová L, Staruchová M, Volkovová K. 2012. Association between the human immune response and body mass index. Hum Immunol. 73(5):480–485.
   PubMed Web of Science ®Google Scholar
• Impinen A, Longnecker M, Nygaard U, London S, Ferguson K, Haug L, Granum B. 2019. Maternal levels of perfluoroalkyl substances (PFASs) during pregnancy and childhood allergy and asthma-related outcomes and infections in the Norwegian Mother and Child (MoBa) cohort. Environ Intl. 124:462–472.
   PubMed Web of Science ®Google Scholar
• Kato K, Wong L, Jia L, Kuklenyik Z, Calafat A. 2011. Trends in exposure to polyfluoroalkyl chemicals in the U.S. population: 1999–2008. Environ Sci Technol. 45(19):8037–8045.
   PubMed Web of Science ®Google Scholar
• Kielsen K, Shamim Z, Ryder L, Nielsen F, Grandjean P, Budtz-Jorgensen E, Heilmann C. 2016. Antibody response to booster vaccination with tetanus and diphtheria in adults exposed to perfluorinated alkylates. J Immunotoxicol. 13(2):270–273.
   PubMed Web of Science ®Google Scholar
• Klein S, Flanagan K. 2016. Sex differences in immune responses. Nat Rev Immunol. 16(10):626–638.
   PubMed Web of Science ®Google Scholar
• Kvalem H, Nygaard U, Lodrup Carlsen K, Carlsen K, Haug L, Granum B. 2020. Perfluoroalkyl substances, airways infections, allergy and asthma related health outcomes – implications of gender, exposure period and study design. Environ Intl. 134:105259.
   PubMed Web of Science ®Google Scholar
• Looker C, Luster M, Calafat A, Johnson V, Burleson G, Burleson F, Fletcher T. 2014. Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate. Toxicol Sci. 138(1):76–88.
   PubMed Web of Science ®Google Scholar
• Miyamura K, Nishio S, Ito A, Murata R, Kono R. 1974. Micro-cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. I. Studies on factors affecting the toxin and antitoxin titration. J Biol Stand. 2(3):189–201.
   PubMedGoogle Scholar
• Mogensen U, Grandjean P, Heilmann C, Nielsen F, Weihe P, Budtz-Jorgensen E. 2015. Structural equation modeling of immunotoxicity associated with exposure to perfluorinated alkylates. Environ Health. 14:47.
   PubMed Web of Science ®Google Scholar
• Mogensen U, Grandjean P, Nielsen F, Weihe P, Budtz-Jørgensen E. 2015. Breastfeeding as an exposure pathway for perfluorinated alkylates. Environ Sci Technol. 49(17):10466–10473.
   PubMed Web of Science ®Google Scholar
• Mondal D, Lopez-Espinosa M, Armstrong B, Stein C, Fletcher T. 2012. Relationships of perfluorooctanoate and perfluorooctane sulfonate serum concentrations between mother-child pairs in a population with perfluorooctanoate exposure from drinking water. Environ Health Perspect. 120(5):752–757.
   PubMed Web of Science ®Google Scholar
• Nakayama S, Yoshikane M, Onoda Y, Nishihama Y, Iwai-Shimada M, Takagi M, Kobayashi Y, Isobe T. 2019. Worldwide trends in tracing poly- and perfluoroalkyl substances (PFAS) in the environment. Trac Trend Anal Chem. 121:115410.
   Web of Science ®Google Scholar
• Pennings J, Jennen D, Nygaard U, Namork E, Haug L, van Loveren H, Granum B. 2016. Cord-blood gene expression supports that prenatal exposure to perfluoroalkyl substances causes depressed immune functionality in early childhood. J Immunotoxicol. 13(2):173–180.
   PubMed Web of Science ®Google Scholar
• Piasecka B, Duffy D, Urrutia A, Quach H, Patin E, Posseme C, Bergstedt J, Charbit B, Rouilly V, MacPherson CR, et al., The Milieu Intérieur Consortium. 2018. Distinctive roles of age, sex, and genetics in shaping transcriptional variation of human immune responses to microbial challenges. Proc Natl Acad Sci USA. 115(3):E488–E97.
   PubMed Web of Science ®Google Scholar
• Pilkerton C, Hobbs G, Lilly C, Knox S. 2018. Rubella immunity and serum perfluoroalkyl substances: Sex and analytic strategy. PLOS One. 13(9):e0203330.
   PubMed Web of Science ®Google Scholar
• Rubin D. 2008. For objective causal inference, design trumps analysis. Ann Appl Stat. 2(3):808–840.
   Web of Science ®Google Scholar
• Salihovic S, Lind L, Larsson A, Lind P. 2020. Plasma perfluoroalkyls are associated with decreased levels of proteomic inflammatory markers in a cross-sectional study of an elderly population. Environ Intl. 145:106099.
   PubMed Web of Science ®Google Scholar
• Schrenk D, Bignami M, Bodin L, Chipman J, del Mazo J, Grasl-Kraupp B, Hogstrand C, Hoogenboom L, Leblanc J, Nebbia C, EFSA Panel on Contaminants in the Food Chain (EFSA CONTAM Panel), et al. 2020. Risk to human health related to the presence of perfluoroalkyl substances in food. EFSA J. 18(9):e06223.
   PubMed Web of Science ®Google Scholar
• Steenland K, Zhao L, Winquist A, Parks C. 2013. Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly-exposed population of community residents and workers in the mid-Ohio valley. Environ Health Perspect. 121(8):900–905.
   PubMed Web of Science ®Google Scholar
• Steenland K, Zhao L, Winquist A. 2015. A cohort incidence study of workers exposed to perfluorooctanoic acid (PFOA). Occup Environ Med. 72(5):373–380.
   PubMed Web of Science ®Google Scholar
• Stein C, Ge Y, Wolff M, Ye X, Calafat A, Kraus T, Moran T. 2016. Perfluoroalkyl substance serum concentrations and immune response to FluMist vaccination among healthy adults. Environ Res. 149:171–178.
   PubMed Web of Science ®Google Scholar
• Stein C, McGovern K, Pajak A, Maglione P, Wolff M. 2016. Perfluoroalkyl and polyfluoroalkyl substances and indicators of immune function in children aged 12-19 yr: National Health and Nutrition Examination Survey. Pediatr Res. 79(2):348–357.
   PubMed Web of Science ®Google Scholar
• Sunderland E, Hu X, Dassuncao C, Tokranov A, Wagner C, Allen J. 2019. A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects. J Expo Sci Environ Epidemiol. 29(2):131–147.
   PubMed Web of Science ®Google Scholar
• Timmermann C, Budtz-Jørgensen E, Jensen T, Osuna C, Petersen M, Steuerwald U, Nielsen F, Poulsen L, Weihe P, Grandjean P. 2017. Association between perfluoroalkyl substance exposure and asthma and allergic disease in children as modified by MMR vaccination. J Immunotoxicol. 14(1):39–49.
   PubMed Web of Science ®Google Scholar
• Timmermann C, Jensen K, Nielsen F, Budtz-Jorgensen E, van der Klis F, Benn C, Grandjean P, Fisker A. 2020. Serum perfluoroalkyl substances, vaccine responses, and morbidity in a cohort of Guinea-Bissau children. Environ Health Perspect. 128:87002.
   PubMed Web of Science ®Google Scholar
• van Loveren H, Germolec D, Koren H, Luster M, Nolan C, Repetto R, Smith E, Vos J, Vogt R. 1999. Report of the Bilthoven Symposium: Advancement of epidemiological studies in assessing the human health effects of immunotoxic agents in environment and the workplace. Biomarkers. 4:135–157.
   PubMedGoogle Scholar
• Xu Y, Li Y, Scott K, Lindh C, Jakobsson K, Fletcher T, Ohlsson B, Andersson E. 2020. Inflam-matory bowel disease and biomarkers of gut inflammation and permeability in a community with high exposure to perfluoroalkyl substances through drinking water. Environ Res. 181:108923.
   PubMed Web of Science ®Google Scholar
• Zeng X, Bloom M, Dharmage S, Lodge C, Chen D, Li S, Guo Y, Roponen M, Jalava P, Hirvonen M, et al. 2019. Prenatal exposure to perfluoroalkyl substances is associated with lower hand, foot and mouth disease viruses antibody response in infancy: Findings from the Guangzhou Birth Cohort Study. Sci Total Environ. 663:60–67.
   PubMed Web of Science ®Google Scholar
• Zeng X, Li Q, Chu C, Ye W, Yu S, Ma H, Zeng X, Zhou Y, Yu H, Hu L, et al. 2020. Alternatives of perfluoroalkyl acids and hepatitis B virus surface antibody in adults: Isomers of C8 health project in China. Environ Pollut. 259:113857.
   PubMed Web of Science ®Google Scholar